This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Roche Glycart Ag. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: **The Innovative Contributions of Claudia Ferrera Koller**
Introduction
Claudia Ferrera Koller is a distinguished inventor based in Zug, Switzerland. She has made significant strides in the field of biotechnology, particularly through her groundbreaking work on antigen binding molecules, which has potential therapeutic applications in treating diseases.
Latest Patents
Claudia holds one notable patent titled "Antigen binding molecules with increased Fc receptor binding affinity and effector function." This innovation focuses on antigen binding molecules (ABMs), specifically recombinant monoclonal antibodies that include chimeric, primatized, or humanized antibodies targeting human CD20. The patent also encompasses nucleic acid molecules encoding these ABMs, along with the associated vectors and host cells. Furthermore, her invention addresses novel methods for producing ABMs and utilizing them for disease treatment. A key aspect of her patent is the enhancement of glycosylation in antibodies to improve their therapeutic efficacy, particularly in increasing Fc receptor binding and effector function.
Career Highlights
Claudia is currently associated with Roche Glycart AG, a prominent company in the field of biopharmaceuticals. Her role involves developing innovative solutions that leverage her expertise in antibody technology, contributing to advancements in medical treatments and therapies.
Collaborations
Throughout her career, Claudia has collaborated with esteemed professionals including Pablo Umaña and Peter Brünker. These partnerships emphasize the collective effort in driving forward research and innovation in biotechnology, merging their expertise to foster groundbreaking discoveries.
Conclusion
Claudia Ferrera Koller exemplifies a commitment to innovation and excellence in her field. Her patent not only showcases her creativity and expertise but also highlights the potential impact of her work on future therapeutic strategies. As biotechnology continues to evolve, inventors like Claudia play a critical role in shaping the future of healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile